Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$3.90
-0.4%
$4.19
$2.20
$5.42
$233.23M0.51213,216 shs103,929 shs
Positron Corp. stock logo
POSC
Positron
$1.82
-3.2%
$1.84
$1.25
$2.74
$59.79M0.1466,941 shs12,330 shs
RxSight, Inc. stock logo
RXST
RxSight
$5.20
-2.4%
$6.52
$5.14
$16.36
$215.28M1.15852,623 shs341,133 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$3.56
+2.8%
$1.98
$1.17
$7.78
$230.55M1.39761,042 shs390,700 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
0.00%-3.69%-2.01%-10.73%+37.19%
Positron Corp. stock logo
POSC
Positron
0.00%+1.62%+5.03%-21.99%+9.14%
RxSight, Inc. stock logo
RXST
RxSight
0.00%-12.48%-24.61%-29.96%-64.58%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%+24.46%+91.16%+108.43%-39.93%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$3.90
-0.4%
$4.19
$2.20
$5.42
$233.23M0.51213,216 shs103,929 shs
Positron Corp. stock logo
POSC
Positron
$1.82
-3.2%
$1.84
$1.25
$2.74
$59.79M0.1466,941 shs12,330 shs
RxSight, Inc. stock logo
RXST
RxSight
$5.20
-2.4%
$6.52
$5.14
$16.36
$215.28M1.15852,623 shs341,133 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$3.56
+2.8%
$1.98
$1.17
$7.78
$230.55M1.39761,042 shs390,700 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
0.00%-3.69%-2.01%-10.73%+37.19%
Positron Corp. stock logo
POSC
Positron
0.00%+1.62%+5.03%-21.99%+9.14%
RxSight, Inc. stock logo
RXST
RxSight
0.00%-12.48%-24.61%-29.96%-64.58%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%+24.46%+91.16%+108.43%-39.93%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.57
Moderate Buy$13.60249.17% Upside
Positron Corp. stock logo
POSC
Positron
0.00
N/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
1.93
Reduce$9.4481.62% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
1.86
Reduce$4.7734.14% Upside

Current Analyst Ratings Breakdown

Latest POSC, OBIO, TMCI, and RXST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2026
RxSight, Inc. stock logo
RXST
RxSight
UpgradeSell (E+)Sell (D-)
5/19/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Lower Price TargetBuy$12.00 ➝ $10.00
5/14/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Reiterated RatingBuy$10.00
5/13/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Boost Price TargetOverweight$12.00 ➝ $13.00
5/7/2026
RxSight, Inc. stock logo
RXST
RxSight
DowngradeSell (D-)Sell (E+)
5/7/2026
RxSight, Inc. stock logo
RXST
RxSight
Lower Price TargetEqual Weight$11.00 ➝ $9.00
5/7/2026
RxSight, Inc. stock logo
RXST
RxSight
Lower Price TargetBuy$13.00 ➝ $11.00
4/21/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
DowngradeSell (D-)Sell (E+)
4/20/2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Reiterated RatingSell (E+)
4/2/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Reiterated RatingSell (D-)
3/12/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Reiterated RatingBuy$20.00
(Data available from 6/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$33.48M6.97N/AN/A$0.95 per share4.10
Positron Corp. stock logo
POSC
Positron
$460K129.97N/AN/A$0.04 per share45.50
RxSight, Inc. stock logo
RXST
RxSight
$134.48M1.60N/AN/A$6.70 per share0.78
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$212.69M1.08N/AN/A$1.37 per share2.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$52.70M-$0.97N/AN/AN/A-166.96%-157.46%-60.18%8/11/2026 (Estimated)
Positron Corp. stock logo
POSC
Positron
-$10.60M-$0.33N/AN/AN/A-1,996.75%-996.81%-272.52%N/A
RxSight, Inc. stock logo
RXST
RxSight
-$38.94M-$1.13N/AN/AN/A-36.58%-17.01%-15.12%8/6/2026 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$59M-$0.97N/AN/AN/A-29.44%-67.04%-30.28%8/6/2026 (Estimated)

Latest POSC, OBIO, TMCI, and RXST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Positron Corp. stock logo
POSC
Positron
N/A-$0.04N/A-$0.04N/A$0.11 million
5/12/2026Q1 2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.40-$0.33+$0.07-$0.33$0.92 million$0.11 million
5/8/2026Q1 2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million
3/31/2026Q4 2025
Positron Corp. stock logo
POSC
Positron
N/A-$0.22N/A-$0.22N/A$0.11 million
3/12/2026Q4 2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.38$0.26+$0.64$0.26$0.93 million$30.92 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
Positron Corp. stock logo
POSC
Positron
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
0.35
7.03
7.01
Positron Corp. stock logo
POSC
Positron
N/A
0.87
0.59
RxSight, Inc. stock logo
RXST
RxSight
N/A
10.20
8.93
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.72
3.58
2.53

Institutional Ownership

CompanyInstitutional Ownership
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.20%
Positron Corp. stock logo
POSC
Positron
N/A
RxSight, Inc. stock logo
RXST
RxSight
78.78%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
7.50%
Positron Corp. stock logo
POSC
Positron
17.20%
RxSight, Inc. stock logo
RXST
RxSight
10.05%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
23.42%
CompanyEmployeesShares OutstandingFree FloatOptionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
459.88 million55.39 millionNot Optionable
Positron Corp. stock logo
POSC
Positron
2032.85 million27.20 millionNot Optionable
RxSight, Inc. stock logo
RXST
RxSight
22041.40 million37.24 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25064.87 million49.68 millionOptionable

Recent News About These Companies

Treace Medical Concepts, Inc.
Treace Medical Concepts: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$3.90 -0.02 (-0.38%)
As of 12:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Positron stock logo

Positron OTCMKTS:POSC

$1.82 -0.06 (-3.19%)
As of 12:06 PM Eastern

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

RxSight stock logo

RxSight NASDAQ:RXST

$5.20 -0.13 (-2.44%)
As of 12:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$3.56 +0.10 (+2.77%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.